variables | HPV Clearance (Univariate) | Â | HPV Clearance (Multivariate) | ||||||
---|---|---|---|---|---|---|---|---|---|
P(Unadjusted) | HR(Unadjusted) | 95%CI | C-index | Â | P(Adjusted) | HR(Adjusted) | 95%CI | C-index | |
Age in years | 0.02* | 0.98 | 0.96-1.00 | 0.54 | Â | Â | Â | Â | Â |
Gravidity | 0.60 | 0.96 | 0.83–1.11 | 0.51 |  |  |  |  |  |
Parity | 0.04* | 0.81 | 0.66–0.99 | 0.57 |  |  |  |  |  |
Menopause | Â | Â | Â | Â | Â | Â | Â | Â | Â |
No | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 0.04* | 0.58 | 0.34–0.98 | 0.55 |  |  |  |  |  |
B Cells | 0.09 | 1.04 | 0.99–1.09 | 0.56 |  | 0.07 | 1.04 | 1.00-1.09 | 0.62 |
T Cells | 0.41 | 0.99 | 0.96–1.02 | 0.51 |  | 0.12 | 0.98 | 0.95–1.01 | 0.59 |
CD4 + T Cells | 0.42 | 0.98 | 0.95–1.02 | 0.52 |  | 0.82 | 1.01 | 0.96–1.05 | 0.59 |
CD8 + T Cells | 0.53 | 0.99 | 0.96–1.02 | 0.48 |  | 0.09 | 0.97 | 0.95-1.00 | 0.60 |
NK Cells | 0.82 | 1.00 | 0.97–1.03 | 0.52 |  | 0.63 | 1.01 | 0.98–1.04 | 0.58 |
CD4/CD8 | 0.49 | 0.90 | 0.67–1.21 | 0.52 |  | 0.63 | 1.09 | 0.77–1.54 | 0.58 |